Related references
Note: Only part of the references are listed.Predictors and prevalence of erectile dysfunction in a racially diverse population
CS Saigal et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
High lung PDE5: A strong basis for treating pulmonary hypertension with PDE5 inhibitors
JD Corbin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Pharmacokinetic variability of anticancer agents
SD Undevia et al.
NATURE REVIEWS CANCER (2005)
Sildenafil: Emerging cardiovascular indications
SG Raja et al.
ANNALS OF THORACIC SURGERY (2004)
Sensitive liquid chromatography assay with ultraviolet detection for a new phosphodiesterase V inhibitor, DA-8159, in human plasma and urine
JY Cho et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects
HJ Shim et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography
HJ Shim et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
Sildenafil for male erectile dysfunction - A systematic review and meta-analysis
HA Fink et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Effects of sildenafil citrate (Viagra) on blood pressure in normotensive and hypertensive men
Y Vardi et al.
UROLOGY (2002)
Pharmacokinetics of sildenafil citrate after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality
DJ Nichols et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients:: a RigiScan and pharmacokinetic study
T Klotz et al.
WORLD JOURNAL OF UROLOGY (2001)
Drug therapy: Erectile dysfunction.
TF Lue
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
